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The future of tissue viability
As we all attend the annual Wounds UK event in Harrogate, it is probably an ideal time to 
reflect on the changes over the last 
twelve months and tissue viability as a 
specialty service. Is there a future for 
tissue viability, or will the speciality be 
subsumed into the role of the generalist 
practitioner? 
The publication of ‘Operational 
Guidance to the NHS: extending patient 
choice of provider’ (Department of 
Health [DH], 2011a) has clearly stated 
that the Government will increase 
choice of services to patients in NHS 
funded care that include venous leg 
ulcer and wound healing. How will this 
look, who will provide this service, can 
we be confident that the providers 
will be specialist in tissue viability? 
More importantly, will any qualified 
provider be able to offer a quality 
service to patients with both simple and 
complicated wounds? Questions we 
need to consider, but we should also see 
this as an opportunity for tissue viability 
practitioners to raise awareness of the 
complexities of this service and how it 
impacts on all types of health care and 
works as part of the multidisciplinary 
team. The field of tissue viability sees no 
age boundaries, with specialists offering 
advice, care and education to paediatric 
and adult patients. 
There are challenges ahead, but we 
must take up the challenge and be 
heard, we need to ensure that we are 
providing audit of services, cost analysis 
of treatments used, metrics of care, 
education programmes for pre and post 
registration practitioners that reflect 
the realities of practice, and providing 
a quality service within the confines of 
available resources. 
Healthcare areas continue to 
demonstrate that they are offering value 
for money, being productive, innovative, 
preventing harm to patients and, above 
all, offering a quality service. Yet, the Safe 
Care Workstream (DH, 2011b) states 
that approximately 10% of patients are 
harmed during a hospital stay. 
To this end, the Safe Care Workstream 
has established a quality improvement 
programme called ‘Safety Express’, to 
help the NHS develop safer system 
in hospitals and community settings. It 
will work towards the shared aim of 
dramatically reducing harm from: 
8 Hospital- and community-acquired 
pressure ulcers
8 Blood clots (deep vein thrombosis 
[DVT] and pulmonary embolism)
8 Urinary tract infections in patients 
with catheters
8 Falls in care settings.
Their ambition is to eliminate harm 
from these conditions in 95% of patients 
by 2012.
There is evidence that much good 
work is being done across the country 
to achieve these ideals — witness some 
of the excellent posters available at 
the conference, clearly evidencing how 
tissue viability practitioners are stepping 
forward and meeting the challenges of 
the quality agenda. Yet, what seems to 
be missing is the sharing of these efforts. 
Practitioners continue to work either 
in isolation or with their local/regional 
groups and work either does not, or is 
slow to transfer to other areas. 
One of the aims of the journal and, 
indeed, the next conference in 2012, will 
be to showcase this excellent work and 
to act as a way of sharing good practice 
across the UK. This becomes more 
imperative as we are increasingly driven 
to meet CQUIN targets and other 
quality standards which are yet to be 
written. These standards need to have 
clinician involvement and engagement, 
and the only way that this will be 
achieved is to be seen as a united force 
with a strong opinion and unified voice. 
It is clear that a quality standard for 
pressure ulcers is on the way. This was 
mentioned, but not discussed in detail, 
at the NICE Pressure Ulcer guideline 
stakeholder meeting. However, it is 
not clear what clinical representation 
there will be on this most important 
group, information on how these are 
developed can be found online at: www.
nice.org.uk/media/6F6/2B/.
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